Literature DB >> 24935104

Understanding electrostatic and steric requirements related to hypertensive action of AT(1) antagonists using molecular modeling techniques.

Danielle da C Silva1, Vinicius G Maltarollo, Emmanuela Ferreira de Lima, Karen Cacilda Weber, Kathia M Honorio.   

Abstract

AT1 receptor is an interesting biological target involved in several important diseases, such as blood hypertension and cardiovascular pathologies. In this study we investigated the main electrostatic and steric features of a series of AT1 antagonists related to hypertensive activity using structure and ligand-based strategies (docking and CoMFA). The generated 3D model had good internal and external consistency and was used to predict the potency of an external test set. The predicted values of pIC50 are in good agreement with the experimental results of biological activity, indicating that the 3D model can be used to predict the biological property of untested compounds. The electrostatic and steric CoMFA maps showed molecular recognition patterns, which were analyzed with structure-based molecular modeling studies (docking). The most and the least potent compounds docked into the AT1 binding site were subjected to molecular dynamics simulations with the aim to verify the stability and the flexibility of the ligand-receptor interactions. These results provided valuable insights on the electronic/structural requirements to design novel AT1 antagonists.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24935104     DOI: 10.1007/s00894-014-2231-7

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  30 in total

1.  Computational studies on HIV-1 protease inhibitors: influence of calculated inhibitor-enzyme binding affinities on the statistical quality of 3D-QSAR CoMFA models.

Authors:  P R Jayatilleke; A C Nair; R Zauhar; W J Welsh
Journal:  J Med Chem       Date:  2000-11-16       Impact factor: 7.446

2.  Multiple templates-based homology modeling enhances structure quality of AT1 receptor: validation by molecular dynamics and antagonist docking.

Authors:  Pandian Sokkar; Shylajanaciyar Mohandass; Murugesan Ramachandran
Journal:  J Mol Model       Date:  2010-10-06       Impact factor: 1.810

3.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.

Authors:  Alexander W Schüttelkopf; Daan M F van Aalten
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-07-21

4.  3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA.

Authors:  C X Xue; S Y Cui; M C Liu; Z D Hu; B T Fan
Journal:  Eur J Med Chem       Date:  2004-09       Impact factor: 6.514

Review 5.  Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications.

Authors:  Juan M Saavedra; Enrique Sánchez-Lemus; Julius Benicky
Journal:  Psychoneuroendocrinology       Date:  2010-10-29       Impact factor: 4.905

Review 6.  New insights into angiotensin receptor actions: from blood pressure to aging.

Authors:  Johannes Stegbauer; Thomas M Coffman
Journal:  Curr Opin Nephrol Hypertens       Date:  2011-01       Impact factor: 2.894

7.  Artificial neural networks and the study of the psychoactivity of cannabinoid compounds.

Authors:  Káthia M Honório; Emmanuela F de Lima; Marcos G Quiles; Roseli A F Romero; Fábio A Molfetta; Albérico B F da Silva
Journal:  Chem Biol Drug Des       Date:  2010-06       Impact factor: 2.817

8.  CoMFA and CoMSIA 3D QSAR and docking studies on conformationally-restrained cinnamoyl HIV-1 integrase inhibitors: exploration of a binding mode at the active site.

Authors:  John K Buolamwini; Haregewein Assefa
Journal:  J Med Chem       Date:  2002-02-14       Impact factor: 7.446

9.  Interaction of Phe8 of angiotensin II with Lys199 and His256 of AT1 receptor in agonist activation.

Authors:  K Noda; Y Saad; S S Karnik
Journal:  J Biol Chem       Date:  1995-12-01       Impact factor: 5.157

10.  Molecular features related to HIV integrase inhibition obtained from structure- and ligand-based approaches.

Authors:  Luciana L de Carvalho; Vinícius G Maltarollo; Emmanuela Ferreira de Lima; Karen C Weber; Kathia M Honorio; Albérico B F da Silva
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.